Background illustration for clinical trials search

Paid Clinical Trials Utah

Discover 1,094 paid clinical trials in Utah. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Charlotte NC, Canton OH, Jeffersonville IN, Houston TX,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase3, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Halifax, Quebec, Sherbrooke, Commack NY, Seaford NY,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase3, Recruiting

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Sherbrooke, Glen Oaks NY, Kingston, Miami Gardens FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07196501

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Boston MA, New Haven CT, Sherbrooke, New York NY,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase3, Recruiting

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

for
Ureteral Stricture
Location: New York NY, Orlando FL, Indianapolis IN, Dallas TX,
Sponsor: Urotronic Inc.

Sex: All

Age: 18+

Code: NCT07020520

Recruiting

Decreasing Nightmares in Adults With Narcolepsy

for
Narcolepsy, Narcolepsy Type 1, Narcolepsy With Cataplexy,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06383806

Recruiting

Continued Pressure for Alveolar Protection (CPAP Trial)

for
Bronchopulmonary Dysplasia (BPD)
Location: Philadelphia PA, Durham NC, Cleveland OH, Atlanta GA,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT07417111

Recruiting

Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation

for
Aphasia, Broca's Aphasia
Location: Charleston SC, Columbia SC, Salt Lake City UT
Sponsor: University of South Carolina

Sex: All

Age: 25 - 70+

Code: NCT07688551

Phase2, Phase3, Recruiting

Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects

for
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Location: Salt Lake City UT
Sponsor: AnHorn Medicines Co. Ltd.

Sex: All

Age: 18 - 65

Code: NCT07697560

Phase1, Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

for
Metastatic Ewing Sarcoma
Location: The Bronx NY, Durham NC, Miami FL, Tampa FL,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1+

Code: NCT07194044

Phase1, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Boston MA, New York NY, Hackensack NJ, Fairfax VA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase1, Recruiting

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

for
Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Location: Richmond VA, Miami FL, Spartanburg SC, Simpsonville SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1 - 6

Code: NCT07406360

Phase3, Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase1, Phase2, Recruiting

A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women

for
Healthy
Location: Salt Lake City UT
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18+

Code: NCT07669077

Phase1, Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Morehead City NC, Greenville NC, Wilmington NC,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase3, Recruiting

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC),
Location: Toronto, Houston TX, San Antonio TX,
Sponsor: ProteinQure Inc.

Sex: All

Age: 18+

Code: NCT07190469

Phase1, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Fall River MA, East Syracuse NY, Richmond VA,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase3, Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for
Asthma
Location: Hawthorne NY, The Bronx NY, Ocean City NJ, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase3, Recruiting

Popular cities in Utah

Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.

Why choose Utah for clinical trials?

Utah offers distinct advantages for those participating in clinical trials. The state's diverse population, combined with its strong emphasis on community health and wellness, enriches the research landscape with a wide range of participants. Utah is also recognized for its innovative research environment, with a notable focus on advancing medical science and exploring cutting-edge treatments, particularly in pediatrics.

Choosing to participate in a clinical trial in Utah means contributing to crucial medical research while benefiting from a supportive and well-established clinical research system. Utah’s commitment to excellence in research, along with its collaborative approach and advanced facilities, makes it an excellent choice for those looking to engage in meaningful and impactful studies.

Common conditions studied in Utah

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Utah